Shares of The Clorox Company (NYSE:CLX) have earned an average recommendation of “Hold” from the fourteen analysts that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $126.88.

CLX has been the subject of several recent research reports. Jefferies Group LLC reissued a “hold” rating and issued a $132.00 price target on shares of The Clorox in a research report on Wednesday, November 1st. Zacks Investment Research cut shares of The Clorox from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Morgan Stanley decreased their price target on shares of The Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research report on Thursday, November 2nd. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of The Clorox in a research report on Sunday, October 8th. Finally, BMO Capital Markets reissued a “buy” rating and issued a $150.00 price target on shares of The Clorox in a research report on Thursday, October 5th.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of The Clorox stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the sale, the senior vice president now directly owns 10,896 shares in the company, valued at approximately $1,421,492.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of The Clorox stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the stock. Janus Henderson Group PLC increased its stake in The Clorox by 8,008.5% in the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock valued at $176,340,000 after purchasing an additional 1,307,153 shares during the period. Vanguard Group Inc. increased its stake in The Clorox by 2.6% in the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares during the period. APG Asset Management N.V. increased its stake in The Clorox by 30.9% in the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock valued at $171,736,000 after purchasing an additional 307,700 shares during the period. Ameriprise Financial Inc. increased its stake in The Clorox by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after purchasing an additional 265,200 shares during the period. Finally, Renaissance Technologies LLC increased its stake in The Clorox by 24.5% in the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after purchasing an additional 263,700 shares during the period. Hedge funds and other institutional investors own 72.74% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.watchlistnews.com/the-clorox-company-clx-receives-126-88-average-target-price-from-analysts/1722586.html.

The Clorox (NYSE CLX) traded down $0.20 during trading hours on Monday, hitting $134.95. 511,600 shares of the company were exchanged, compared to its average volume of 812,283. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. The stock has a market cap of $17,426.05, a PE ratio of 24.35, a P/E/G ratio of 3.69 and a beta of 0.39. The Clorox has a 1 year low of $112.28 and a 1 year high of $141.76.

The Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.41 by $0.05. The Clorox had a net margin of 11.84% and a return on equity of 161.59%. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the company posted $1.36 EPS. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. equities analysts predict that The Clorox will post 5.58 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.49%. The Clorox’s payout ratio is 61.88%.

The Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox Company and related companies with Analyst Ratings Network's FREE daily email newsletter.